Molnupiravir: an antiviral drug against COVID-19
Author:
Publisher
Springer Science and Business Media LLC
Subject
Virology,General Medicine
Link
https://link.springer.com/content/pdf/10.1007/s00705-023-05881-9.pdf
Reference49 articles.
1. Keni R, Alexander A, Nayak PG, Mudgal J, Nandakumar K (2020) COVID-19: Emergence, Spread, Possible Treatments, and Global Burden. 8
2. Girum T, Lentiro K, Geremew M, Migora B, Shewamare S (2020) Global strategies and effectiveness for COVID-19 prevention through contact tracing, screening, quarantine, and isolation: a systematic review. Trop Med Health 48(1):1–15
3. Singh AK, Singh A, Singh R, Misra A (2021) Molnupiravir in COVID-19: A systematic review of literature. Diabetes Metab Syndr 15(6):102329
4. Gorbalenya AE, Baker SC, Baric RS, de Groot RJ, Drosten C, Gulyaeva AA et al (2020) The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol 5(4):536–544
5. Guan W-j, Ni Z-y, Hu Y, Liang W-h, Ou C-q, He J-x et al (2020) Clinical characteristics of coronavirus disease 2019 in China. N Engl J Med 382(18):1708–1720
Cited by 5 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. In silico study of RNA polymerase inhibitor drugs for Rift Valley fever virus using RdRp protein as the target;Journal of Pharmacy & Pharmacognosy Research;2025-01-01
2. Structural basis for the inhibition of coronaviral main proteases by PF-00835231;Acta Biochimica et Biophysica Sinica;2024-07-01
3. Structural basis for the inhibition of coronaviral main proteases by PF-00835231;2024-04-22
4. Proof-of-concept studies with a computationally designed M pro inhibitor as a synergistic combination regimen alternative to Paxlovid;Proceedings of the National Academy of Sciences;2024-04-15
5. Structural Basis for the Inhibition of Coronaviral Main Proteases by Pf-00835231;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3